|
|
Blood eosinophils and mortality in patients with acute respiratory distress syndrome: A propensity score matching analysis
|
Hao-tian Chen, Jian-feng Xu, Xiao-xia Huang, Ni-ya Zhou, Yong-kui Wang, Yue Mao
|
|
|
Table 2 Comparisons of outcome characteristics between the EOS counts <2% and EOS counts ≥2% groups
|
|
Variables | Total (n=2,567) | Patients who used corticosteroids (n=436) | Patients who did not use corticosteroids (n=2,131) | EOS counts <2% (n=2,110) | EOS counts ≥2% (n=457) | P | EOS counts <2% (n=389) | EOS counts ≥2% (n=47) | P | EOS counts <2% (n=1,721) | EOS counts ≥2% (n=410) | P | 28-day mortality, n (%) | 536 (25.40) | 85 (18.60) | 0.002 | 139 (35.73) | 21 (44.68) | 0.229 | 397 (23.07) | 64 (15.61) | 0.001 | ICU mortality, n (%) | 448 (21.23) | 71 (15.54) | 0.006 | 125 (32.13) | 22 (46.81) | 0.144 | 323 (18.77) | 49 (11.95) | 0.001 | Hospital mortality, n (%) | 527 (24.98) | 81 (17.72) | 0.001 | 140 (35.99) | 21 (44.68) | 0.244 | 387 (22.49) | 60 (14.63) | <0.001 | Length of ICU stay (days) | 6.17 (3.67-11.92) | 6.21 (3.58-12.38) | 0.918 | 7.29 (4.33-14.13) | 7.33 (3.71-12.13) | 0.538 | 5.96 (3.46-11.33) | 6.08 (3.46-12.63) | 0.629 | Length of hospital stay (days) | 12.00 (7.25-20.25) | 11.92 (7.38-21.83) | 0.340 | 14.17 (8.25-23.83) | 12.21 (6.88-16.92) | 0.094 | 11.75 (7.16-19.00) | 11.89 (7.38-22.88) | 0.392 |
|
|
|